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OBJECTIVE — Iron deﬁciency has been reported to elevate A1C levels apart from glycemia.
We examined the inﬂuence of iron deﬁciency on A1C distribution among adults without
diabetes.
RESEARCH DESIGN AND METHODS — Participants included adults without self-
reported diabetes or chronic kidney disease in the National Health and Nutrition Examination
Survey 1999–2006 who were aged 18 years of age and had complete blood counts, iron
studies, and A1C levels. Iron deﬁciency was deﬁned as at least two abnormalities including free
erythrocyte protoporphyrin 70 g/dl erythrocytes, transferrin saturation 16%, or serum
ferritin 15 g/l. Anemia was deﬁned as hemoglobin 13.5 g/dl in men and 12.0 g/dl in
women.
RESULTS — Among women (n  6,666), 13.7% had iron deﬁciency and 4.0% had iron
deﬁciency anemia. Whereas 316 women with iron deﬁciency had A1C 5.5%, only 32 women
withirondeﬁciencyhadA1C6.5%.Amongmen(n3,869),only13hadirondeﬁciencyand
A1C 5.5%, and only 1 had iron deﬁciency and A1C 6.5%. Among women, iron deﬁciency
was associated with a greater odds of A1C 5.5% (odds ratio 1.39 [95% CI 1.11–1.73]) after
adjustment for age, race/ethnicity, and waist circumference but not with a greater odds of A1C
6.5% (0.79 [0.33–1.85]).
CONCLUSIONS — Iron deﬁciency is common among women and is associated with shifts
in A1C distribution from 5.5 to 5.5%. Further research is needed to examine whether iron
deﬁciency is associated with shifts at higher A1C levels.
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A
1C is formed by the glycation of the
terminalvalineofthe-chainofhe-
moglobin. It is used commonly as a
screeningtestfordiabetesinclinicalprac-
tice (1). A1C may be less susceptible than
other measures of glycemia to temporary
ﬂuctuations caused by diet, physical ac-
tivity, or illness as well as differences in
local testing standards; as a result, an ex-
pert committee has recently endorsed an
A1C6.5%asdiagnosticfordiabetes(1).
Previous studies have reported that
depletion of iron stores may alter the gly-
cation rate of hemoglobin and elevate
A1C concentrations, independent of gly-
cemia (2). Iron deﬁciency may be present
without associated anemia (3). Although
iron deﬁciency is the most common nu-
tritional deﬁciency (3), the clinical rele-
vanceofirondeﬁciencyontheuseofA1C
as a screening test for diabetes has not
been studied. Reproductive-age women
are particularly vulnerable to iron deﬁ-
ciency, reﬂecting iron loss through men-
struation and pregnancy. In the Third
National Health and Nutrition Examina-
tion Survey (NHANES) 1988–1994 and
later NHANES waves, 11% of women
had iron deﬁciency (3,4).
Usingarecentpopulation-basedsam-
ple of U.S. adults, we examined the dis-
tribution of A1C by iron deﬁciency status
among adults without known diabetes.
We hypothesized that adults with iron
deﬁciency would be more likely to have
elevated A1C levels, even after consider-
ation of fasting plasma glucose. We also
hypothesized that any differences would
persist after adjustment for other factors
associated with A1C and iron deﬁciency,
including age, race/ethnicity, and waist
circumference.
RESEARCH DESIGN AND
METHODS— We used data from the
NHANES 1999–2006 conducted by the
National Center for Health Statistics of
the Centers for Disease Control and Pre-
vention to assess the health and nutri-
tional status of the U.S. population. The
NHANES 1999–2006 included a nation-
ally representative probability sample of
the U.S. civilian noninstitutionalized
population, identiﬁed through a complex
multistage cluster sampling design (5).
During a household interview, partici-
pants provided information on sociode-
mographics and health status, and
physicians and health care technicians
conducted a standard examination on
sampled subjects within 4 weeks of the
interview. For the purposes of this analy-
sis, we included NHANES 1999–2006
participants aged 18 years who had a
complete blood count, iron studies, and
A1Clevels.Weexcludedindividualswith
knownself-reporteddiabetes(n1,029)
and pregnant women (n  1,144). Con-
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erythrocyte survival may proportionately
decrease A1C levels and are also associ-
ated with iron deﬁciency, (6), but the de-
gree of renal impairment at which anemia
occurs is unclear (7). Therefore, we also
excluded participants with chronic kid-
ney disease (n  1,266), deﬁned as a glo-
merular ﬁltration rate (GFR) 60 ml/min
per1.73m
2orGFRfrom60to90ml/min
per 1.73 m
2 with microalbuminuria (8),
from the primary analysis.
Main outcome measures
A1C measurements for NHANES 1999–
2004 were performed by the Diabetes Di-
agnostic Laboratory at the University of
Missouri–Columbia using Primus
CLC330 and Primus CLC 385 analyzers
(Primus Corporation, Kansas City, MO).
A1C measurements in NHANES 2005–
2006 were performed by the Diabetes
Laboratory at the University of Minnesota
using a Tosoh A1C 2.2 Plus Glycohemo-
globinAnalyzer(TosohMedics,SanFran-
cisco, CA). Both assays use a high-
performance liquid chromatography
system and were standardized to the Dia-
betes Control and Complications Trial
reference method. Collection procedures
were similar from 1999 to 2004 and be-
tween 2005 and 2006, intra-assay varia-
tion was 3% for both assays, and assays
correlated at 0.98, with similar values for
the range of A1C examined in this analy-
sis (9–11). Therefore, for the purposes of
this analysis, we combined the results
from the two assays.
According to analyses of 1999–2004
NHANES data, an A1C of 5.5% has a sen-
sitivity of 89% and a speciﬁcity of 80%
compared with fasting glucose, and an
A1C of 6.1% has a sensitivity of 67% and
a speciﬁcity of 98% compared with fast-
ing glucose levels 126 mg/dl to detect
diabetes(12).In2009,anexpertcommit-
tee endorsed A1C as a diagnostic test for
diabetes (1). For the purposes of this re-
port, A1C was categorized in two ways.
Because of the distribution of A1C values
(Table 1), we examined a cut point of
5.5 vs. 5.5%, and because of the ex-
pert committee recommendation, we ex-
amined a cut point of 6.5 vs. 6.5%.
Independent variables
Iron status may be assessed through sev-
eral laboratory tests. We used the deﬁni-
tion applied previously in the Third
NHANES and the NHANES 1999–2000
for iron deﬁciency, i.e., any two of the
following three indexes: erythrocyte pro-
toporphyrin levels 70 g/dl erythro-
cytes, ferritin 15 g/l, and transferrin
saturation levels 16% (3). The presence
of anemia was deﬁned as an Hb level of
12.0g/dlforwomenand13.5g/dlfor
men (3).
We controlled for several factors that
could have served as confounders be-
cause of their associations with both iron
deﬁciency and A1C, including age
(13,14), race (13,14), and obesity, partic-
ularly visceral adiposity (14,15). In
NHANES 1998–2006, race/ethnicity was
deﬁned as non-Hispanic white, non-
Hispanic black, Mexican American, and
other race. For the total estimates of iron
deﬁciency, all racial/ethnic groups were
combined. BMI was calculated as weight
in kilograms divided by the square of
heightinmeters,andwaistcircumference
is reported in centimeters. In women, we
also controlled for self-report of parity
and hysterectomy status, as these may be
associated with iron deﬁciency (16) and
glucose tolerance (17,18).
Statistical analyses
WeperformedanalysesusingSASfordata
managementandSUDAANtoaccountfor
unequal probabilities of selection,
planned oversampling, and the complex
sample design of the NHANES (5). All
analyses were stratiﬁed by sex, as anemia
cut points for hemoglobin levels differ by
sex. We compared categorical variables
by iron deﬁciency status using 
2 tests
and continuous variables using ANOVA.
We constructed several types of multiva-
riablemodels.First,wecomparedthedis-
tribution of A1C between participants
with and without iron deﬁciency. Of par-
ticipants, 97% had A1C levels 5.5 or
5.5–6.0% (Table 1); therefore, we used
5.5% as a cut point in one analysis and
6.5% as a cut point in another analysis.
We used multiple logistic regression
models to describe the odds of having
A1C levels 5.5 vs. 5.5% or 6.5 vs.
6.5% by iron deﬁciency status, before
and after adjustment for age, race/
ethnicity, waist circumference, and,
among women, parity (as a continuous
variable) and hysterectomy status. Mod-
els using BMI instead of waist circumfer-
ence were also constructed with similar
results, so only the results using waist cir-
cumference are shown. We also calcu-
lated the predicted prevalence of an
elevated A1C level according to iron deﬁ-
ciency status, and differences between
prevalences before and after adjustment
for the covariates mentioned above.
We conducted several sensitivity
analyses.First,weusedmultiplelinearre-
gression to calculate the adjusted preva-
lence of mean A1C levels by iron
deﬁciency status before and after adjust-
ment for the above factors. Because of the
skewed A1C distribution, we log-
transformedA1Clevelsbutobtainedsim-
ilar results and, therefore, for ease of
interpretation, present the analysis with-
out log transformation. To determine
whether the association between iron de-
ﬁciency and A1C was independent of gly-
cemia,weexaminedthesubpopulationof
men and women in our sample who also
underwent a fasting glucose measure-
ment (n  2,796 women and n  1,680
men). Approximately one-half of
NHANES participants were sampled to
attend the morning session. These partic-
ipants were instructed to fast at least 9 h
before the appointment time. Fasting
plasma glucose values are available for
those adults who attended the morning
examination and were fasting 8h .I n
this subpopulation, we included fasting
glucose levels as a continuous covariate
when we examined the association be-
tween iron deﬁciency and A1C levels. Be-
cause of the small number of male
participants with both elevated A1C lev-
els and iron deﬁciency, we performed
sensitivity analyses only among women
participants. In the third sensitivity anal-
ysis, we also included adults with GFR
from 60 to 90 ml/min per 1.73 m
2 with
microalbuminuria, resulting in an in-
crease in sample size from 2,993 women
and 1,799 men to 3,033 women and
2,044men.Finally,weexaminedthesub-
population of adults with anemia to de-
termine whether any associations were
more pronounced in the subgroup of
women with iron deﬁciency anemia, but
we did not ﬁnd this (results not shown).
RESULTS— Unadjusted characteris-
tics of men and women with and without
iron deﬁciency are shown in Table 1.
Among women (n  6,666), 13.7% (n 
1,150) had iron deﬁciency, and, after
consideration of sample weighting, 30%
of iron-deﬁcient women also had anemia.
Among men (n  3,869), 1.6% (n  75)
had iron deﬁciency, and, after consider-
ation of sample weighting, 33% of iron-
deﬁcient men also had anemia. Among
women, 316 participants with iron deﬁ-
ciency had an A1C 5.5%; 32 partici-
pants with iron deﬁciency had an A1C
6.5%. Among men, 13 participants
with iron deﬁciency had an A1C 5.5%,
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ﬁciency had an A1C 6.5%.
Characteristics of iron-deﬁcient
adults differed among men and women.
Women with iron deﬁciency tended to be
aged 50 years and were more likely to
be African American or Hispanic, to be
obese, and to have a greater waist circum-
ference and were less likely to have had a
hysterectomy. Men with iron deﬁciency
tended to be aged 50 years and to have
greater waist circumference. In the sub-
population of participants who had fast-
ing glucose levels, iron-deﬁcient women
had slightly lower fasting glucose com-
pared with non–iron-deﬁcient women,
but similar proportions had fasting glu-
cose126mg/dl.Iron-deﬁcientmenhad
mean fasting glucose values similar to
those of non–iron-deﬁcient men, al-
though no iron-deﬁcient men had a fast-
ing glucose 126 mg/dl. Among women,
unadjustedA1Cmeanlevelsdidnotdiffer
between iron-deﬁcient and non–iron-
deﬁcient adults; A1C distributions were
primarilyshiftedfrom5.5to5.5–5.9%.
Amongmen,unadjustedmeanA1Clevels
were higher in iron-deﬁcient men com-
pared with those for iron-sufﬁcient men.
TheoddsofhavinganA1C5.5%by
iron deﬁciency status are shown in Table
2.Amongwomen,irondeﬁciencywasas-
sociated with increased odds of an A1C
5.5% before and after adjustment for
age and race/ethnicity, waist circumfer-
ence, parity, and hysterectomy. Among
menwithandwithoutirondeﬁciency,the
odds of having an A1C 5.5% did not
reach statistical signiﬁcance after adjust-
mentforcovariates(Table2).Theoddsof
having an A1C 6.5 by iron-deﬁciency
statusforwomenisalsoshowninTable2,
with no statistically signiﬁcant associa-
tion, although the number of iron-
deﬁcient women with A1C 6.5% was
small. Because only one man had iron de-
ﬁciency and an A1C 6.5%, multivariate
regression was not performed.
Table 1—Characteristics of adults aged 18 years and older with and without iron deﬁciency, NHANES 1999–2006
Women Men
Iron
deﬁciency
No iron
deﬁciency P*
Iron
deﬁciency
No iron
deﬁciency P*
Sample size 1,150 (13.7) 5,516 (86.3) 75 (1.6) 3,794 (98.4) 0.001
Age
50 years 88.7 69.4 0.001 63.7 71.2 0.216
50 years 11.3 30.6 36.3 28.9
Race/ethnicity (%)
Non-Hispanic white 56.7 72.4 0.001 75.0 71.8 0.876
African American 18.2 10.9 9.8 9.7
Hispanic 20.7 12.3 11.5 15.0
Other 4.4 4.4 3.7 3.6
BMI (%)
25 kg/m
2 35.7 44.1 0.001 28.0 36.4 0.225
25 to 30 kg/m
2 24.1 26.6 35.2 40.4
30 kg/m
2 40.3 29.3 36.8 23.3
Waist circumference (cm) 94.2  0.8 91.1  0.4 0.001 107.8  3.3 97.0  0.3 0.002
Parity (women only) (%)
0 24.3 27.3 0.157
1 15.9 16.5
2 25.6 27.3
3 18.7 17.3
4 9.1 6.3
5 births 6.4 5.3
Hysterectomy (women only) (%) 5.6 17.6 0.001
Anemia (%) 29.5 2.3 0.001 33.3 3.3 0.001
A1C (%) 5.31  0.02 5.27  0.01 0.127 5.43  0.06 5.29  0.02 0.035
A1C (%)
5.4 73.6 76.5 0.366 54.7 73.9 0.001
5.5–6.0 23.9 20.5 37.9 22.5
6.1–6.4 1.5 1.7 7.3 2.0
6.5–6.9 0.4 0.6 0.0 0.6
7.0–7.9 0.3 0.3 0.0 0.4
8.0–8.9 0.2 0.1 0.1 0.2
9.0 0.3 0.3 0.0 0.4
Fasting glucose (mg/dl) (n  2,993 women,
n  1,799 men) 92.4  0.8 94.2  0.5 0.034 101.5  2.3 98.8  0.6 0.269
Fasting glucose 126 mg/dl (n  2,993
women, n  1,799 men) (%) 99.2 98.5 0.096 100.0 97.3 0.001
Data are n (%), weighted percentage, or means  SE adjusted for complex survey design. Percentages may not total 100 because of rounding, and percentages may
differ from unweighted calculations of percentages. *P value was determined by a design-corrected 
2 test or t test.
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alenceofwomenwithanelevatedA1Cby
ironstatusbeforeandafteradjustmentfor
covariates.Thedifferenceinthepredicted
prevalence of an A1C 5.5% between
women with and without iron deﬁciency
was small although statistically signiﬁ-
cant. There was no signiﬁcant difference
in the predicted prevalence of an A1C
6.5% between women with and with-
out iron deﬁciency, although again the
number of women with iron deﬁciency
and an A1C 6.5% was small.
Sensitivity analyses
Although mean A1C levels differed be-
tween women with and without iron de-
ﬁciency, differences were small. The
mean A1C values among iron-deﬁcient
andnon–iron-deﬁcientwomenwere5.33
and 5.27% after adjustment for age and
race/ethnicity (P  0.002), 5.31 and
5.27% after further adjustment for waist
Table 2—Odds ratios (95% CI) for iron deﬁciency predicting high A1C among adults aged
>18 years, NHANES 1999–2006
Women* Men: A1C
5.5%† A1C 5.5% A1C 6.5%
n 6,666 6,666 3,869
Unadjusted 1.17 (0.95–1.43) 0.82 (0.37–1.80) 2.34 (1.26–4.33)
Adjusted for age, race/ethnicity 1.47 (1.19–1.83) 0.90 (0.42–1.94) 2.03 (0.81–5.08)
Adjusted for age, race/ethnicity,
waist circumference 1.39 (1.11–1.73) 0.79 (0.33–1.85) 1.40 (0.69–2.87)
Adjusted for age, race/ethnicity,
waist circumference, parity,
hysterectomy 1.33 (1.05–1.67) 0.78 (0.32–1.90) NA
Dataareoddsratios(95%CI).Thereferentgroupisadultswhoareiron-sufﬁcient;anoddsratio1indicates
that an iron-deﬁcient adult has greater odds of having an elevated A1C than an iron-sufﬁcient adult, and an
odds ratio 1 indicates that an iron-deﬁcient adult has a lower odds of having an elevated A1C than an
iron-sufﬁcient adult. *316 female participants with iron deﬁciency had a measured A1C 5.5%; 32 female
participants with iron deﬁciency had a measured A1C 6.5%. †13 male participants with iron deﬁciency
had a measured A1C 5.5%; 1 male participant with iron deﬁciency had a measured A1C 6.5%. NA, not
applicable.
Table 3—Predicted prevalence of elevated A1C among adults aged >18 years with and without iron deﬁciency
Predicted prevalence of women
with an A1C 5.5%*
Difference in predicted
prevalence of A1C
5.5% between iron-
deﬁcient and iron-
sufﬁcient women
Predicted percentage of men
with an A1C 5.5%*
Difference in predicted
prevalence of A1C
5.5% between iron-
deﬁcient and iron-
sufﬁcient men Iron-deﬁcient Iron-sufﬁcient Iron-deﬁcient Iron-sufﬁcient
n 1,150 5,516 75 3,794
Unadjusted 26.4  1.8 23.5  0.9 2.8  1.9 45.3  7.5 26.2  1.3 19.1  7.6†
Adjusted for age,
race/ethnicity 29.4  1.8 23.1  0.9 6.3  1.8† 39.5  9.2 26.2  1.3 13.2  9.3
Adjusted for above,
and waist
circumference 27.9  1.7 23.1  0.9 4.8  1.7† 31.8  6.0 26.1  1.3 5.7  6.2
Adjusted for above,
and parity,
hysterectomy 27.4  1.7 23.3  1.0 4.1  1.7†
Predicted prevalence of women
with an A1C 6.5%‡
Difference in predicted
prevalence of A1C
6.5% between iron-
deﬁcient and iron-
sufﬁcient women Iron-deﬁcient Iron-sufﬁcient
n 1,150 5,516
Unadjusted 1.1  0.4 1.3  0.2 0.2  0.4
Adjusted for age,
race/ethnicity
1.1  0.4 1.3  0.2 0.1  0.4
Adjusted for above
and waist
circumference
1.0  0.4 1.3  0.2 0.3  0.4
Adjusted for above
and parity,
hysterectomy
1.0  0.4 1.3  0.2 0.3  0.4
Data are %  SE. *316 female participants with iron deﬁciency and 1,478 without iron deﬁciency had a measured A1C 5.5%, 13 male participants with iron
deﬁciency and 1,178 without iron deﬁciency had a measured A1C 5.5%. †P  0.05. ‡32 female participants with iron deﬁciency and 102 without iron deﬁciency
had a measured A1C  6.5%.
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5.27% after further adjustment for parity
and hysterectomy (P  0.022). The mean
A1C values among iron-deﬁcient men
and non–iron-deﬁcient men were 5.38
and 5.29% after adjustment for age and
race/ethnicity (P  0.22) and 5.29 and
5.29% after further adjustment for waist
circumference (P  0.92).
Whenweexaminedonlywomenwith
a fasting glucose level and included fast-
ing glucose as an adjuster, the odds of
having an A1C 5.5% remained signiﬁ-
cant after adjustment for age, race/
ethnicity, waist circumference, parity and
hysterectomy, and fasting glucose (P 
0.05). Mean A1C levels were also signiﬁ-
cantly different after adjustment for these
factors (P  0.001). When we included
adults with mild renal impairment, the
odds of having an A1C 5.5% with iron
deﬁciency no longer remained signiﬁ-
cantly decreased after adjustment for age,
race/ethnicity, waist circumference, par-
ity, hysterectomy, and fasting glucose
among women (OR 0.73, 95% CI 0.51–
1.04). Among men, the odds of having an
A1C 5.5% with iron deﬁciency re-
mained nonsigniﬁcant (results not
shown).
CONCLUSIONS — The optimal
screening strategies for diabetes in terms
of sensitivity, speciﬁcity, and cost may
vary among different populations based
on demographics and other risk factors
for diabetes. We found that iron deﬁ-
ciency, a common condition among re-
productive-age women, was associated
with shifts in A1C distribution to higher
levels, but this shift occurred primarily
between 5.5 and 5.5–6.0%. Although
we did not ﬁnd an association between
iron deﬁciency and shifts in A1C between
6.5 and 6.5%, few women and men
had both iron deﬁciency and A1C eleva-
tions 6.5, and therefore conclusions re-
gardingirondeﬁciencyandthehighercut
point are limited.
Previous studies of the inﬂuence of
iron deﬁciency and glucose control have
documented the high prevalence of iron
deﬁciency in pregnancy (19) and the as-
sociation with erythrocyte indexes (20).
Inapremenopausalnonpregnantpopula-
tion, Koga et al. (20) found that red cell
counts and A1C were associated in pre-
menopausal women with otherwise nor-
mal glucose tolerance. Hashimoto et al.
(19) found that A1C levels were signiﬁ-
cantly increased in the third trimester
compared with earlier in pregnancy, but
serum glycated albumin did not change;
A1Cwasnegativelycorrelatedwithserum
ferritin and transferrin saturation, sug-
gesting that A1C was inﬂuenced by iron
stores rather than by glucose control.
Furthermore, replacement with iron is
associated with decreases in A1C, inde-
pendent of glucose changes. Coban et al.
(21)foundthatamongnondiabeticadults
withiron-deﬁciencyanemia,theA1Cwas
7.4  0.3% before treatment and 6.2 
0.6% after treatment. Likewise, Tarim et
al. (22) found that A1C in iron-deﬁcient
patients decreased from 7.6  2.6 to
6.2  1.4% after iron therapy (P  0.05),
despite similar glucose levels. We did not
ﬁnd such large shifts in A1C associated
with iron deﬁciency, either because of the
population-based nature of the sample or
differences in A1C assays. In addition, we
did not examine pregnant patients, and
the previous studies of nonpregnant pa-
tients may have included some adults
with undiagnosed diabetes, as suggested
by the A1C levels. In this respect, our re-
sults are similar to a subanalysis of the
Diabetes Control and Complications
Trial, in which comparisons of A1C and
glucoseassociationsweresimilarbetween
premenopausal women and men (23),
suggesting that iron deﬁciency might not
be inﬂuential in larger samples, although
actually iron measurements were not
available in that study.
Whenweexaminedonlywomenwho
underwent a fasting glucose measure-
ment and included fasting glucose as an
adjuster, iron deﬁciency was still associ-
atedwithagreatermeanlevelofA1Cafter
adjustment as well as a greater odds of
having an A1C 5.5%. When we ex-
cluded women who were likely to have
undiagnosed diabetes by fasting glucose
value, iron deﬁciency was still associated
with a higher mean level of A1C after ad-
justment, but the increased odds of hav-
i n ga nA 1 C5.5% was no longer
signiﬁcant. When we included adults
with renal impairment, the association
between iron deﬁciency and A1C was at-
tenuated.Thisresultisconsistentwiththe
observation that factors contributing to
shorter erythrocyte half-life such as renal
diseasemaylowertherangeofA1Cvalues
and reduce the strength of the association
between A1C and factors such as iron
deﬁciency.
Thestrengthsofourreportincludeits
population-based sampling frame, size,
andstandardizedA1Cmeasurementsthat
accountedforfactorsthatmightalterA1C
measures such as hemoglobinopathies.
Our study has several limitations. Iron
studies may be affected by inﬂammation,
and we have limited ability to assess such
inﬂammation. Whereas previous studies
have not shown that adjustment for C-re-
active protein affected estimates of iron
deﬁciency, it is possible that adults more
prone to glucose intolerance and higher
A1C levels were also prone to inﬂamma-
tion that was not detected. However, in-
ﬂammation would be expected to raise
ferritin levels so that adults with iron de-
ﬁciency would be less likely to be diag-
nosed with iron deﬁciency, thus biasing
estimatesofassociationbetweenA1Cand
iron deﬁciency to the null, and we used
a low cutoff for ferritin (15 mg/dl). We
were also unable to account for other fac-
tors that might affect red cell production,
including malignancies and aplastic ane-
mia. These factors might act as effect
modiﬁers by decreasing red cell half-life
and thus artiﬁcially lower A1C, thus re-
ducing the magnitude of the association
and might also act as confounders
through inﬂuencing iron resorption, al-
though we expect that these conditions
were probably uncommon and would
bias any associations to the null. As with
any observational study, residual con-
founding from measurement error may
account for the observed associations,
and multiple testing may have contrib-
uted to chance positive ﬁndings.
In summary, we found that iron deﬁ-
ciency was common among women, this
iron deﬁciency was not necessarily ac-
companied by anemia, and iron deﬁ-
ciency shifted the A1C slightly upward
independent of fasting glucose level.
However, the shift occurred at the lower
end of the A1C spectrum, and we were
unable to conclude whether iron deﬁ-
ciency affected A1C distributions at a
higher cut point of 6.5 vs. 6.5%, a
new recommended diagnostic cut point
(1). Similar relationships were observed
in men, although the proportion of men
with iron deﬁciency was fairly low, pro-
hibiting more deﬁnitive conclusions. Al-
thoughyoungerpopulationsaregenerally
at low risk for diabetes compared with
older populations, the incidence and
prevalence of diabetes are increasing
among younger women and pregnant
women with the obesity epidemic as well
as advancing maternal age (24,25). Re-
search needs to be done to conﬁrm that
iron deﬁciency does not affect A1C read-
ings in the population with known diabe-
tes as well as at diagnostic cut points
5.5%.
Iron deﬁciency and A1C levels in NHANES
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